Background: Wide metastasis is one of characteristics of ovarian cancer. Cancer stem cells, as a source in cancer invasion and metastasis, possess powerful potential of differentiation. Scaffolding IQ domain GTPase-activating protein 1 (IQGAP1) plays a key role in the invasion and metastasis of cancer cells, but IQGAP1's role in cancer stem cells including ovarian cancer was unclear. Methods: Spheroid culture with serum-free medium was used for enriching ovarian cancer stem cell-like cells (CSC-LCs) from 3AO cell line, and a medium with 10% fetal bovine serum was used to induce the differentiation of CSC-LCs. Immunofluorescence was for detecting the stem markers OCT4 and SOX2. The quantitative real-time-polymerase chain reaction and Western blotting were performed to determine the messenger RNA and protein expression of IQGAP1, respectively. The capacity of cell invasion was evaluated by transwell chamber assay. Results: Ovarian CSC-LCs obtained through spheroid culture showed irregularly elongated appearance, CD24 negative, and OCT4 and SOX2 positive. IQGAP1 expression was decreased in ovarian CSC-LCs compared with parental 3AO cells, but increased de novo during the differentiation of CSC-LCs. Knockdown of IQGAP1 by specific small interfering RNA remarkably weakened invasion capacity of 2-day differentiated ovarian CSC-LCs. Conclusions: Increased IQGAP1 expression during the differentiation of CSC-LCs is involved in an aggressive cell behavior, which may contribute to metastasis of ovarian cancer.
patients being diagnosed with advanced-stage disease at the very start. 1 With further research, genetic and phenotypic heterogeneity of malignancies need more complex models to describe the tumour-initiating properties. The cancer stem cell concept actually derives from prominence of normal tissue hierarchies to tumor and was reported as a population of undifferentiated cells from a primary tumor involved in tumor progression and metastasis. First identified in acute myloid leukemia and breast cancer, 2, 3 cancer stem cells have soon been demonstrated in other solid malignancies, such as brain tumor, 4 colorectal cancer, 5, 6 ovarian cancer, 7, 8 and others. Markers of certain cancer stem cells were gradually identified for isolating the minor subpopulations. Our previous study has identified CD24(j) cells from serous ovarian cancer cell line 3AO during serum-free starvation culture, which have higher capacity of tumorigenesis, drug resistance, self-renewal, and differentiation abilities, which means that CD24(j) cells exhibit the characters of ovarian cancer stem cell-like cells (CSC-LCs). 8, 9 Unlike normal counterparts, cancer stem cells endow tumor-initiating metastasis capacity that facilitates the final step of the distant organ metastasis. In this process, dynamic rearrangement of cell-cell adhesion and polarized cell migration are 2 of the major events in tumor metastasis in which Rho family small GTPases and their effectors, IQ domain GTPaseactivating protein 1 (IQGAP1), are involved. IQGAP1, from the IQGAP family including 3 members, is ubiquitously expressed in humans. 10 IQGAP1 acts in the regulation of cytoskeletal architecture and cell adhesion through binding to various regulators/effectors. 11 In the physiological processes, regulated by activated Rac1, E-cadherinYA-cateninYIQGAP1 complex exists in a dynamic equilibrium of strong and weak adhesion. 12 The evidences have shown an altered IQGAP1 expression in various cancer tissues. Compared with normal tissues, IQGAP1 overexpression is found in colorectal carcinoma, 13 breast cancer, 14 astrocytoma, 15 and squamous cell carcinoma of the head and neck. 16 For instance, Clark et al 17 identified by a screen of genes that IQGAP1 and its binding proteins calmodulin and ERK showed a greater than 2.5-fold increase in metastatic cells in a mouse model with metastatic melanoma. However, the role of IQGAP1 in cancer stem cell including ovarian cancer is unclear up to date. In this study, we used spheres as an ovarian CSC-LC model to observe the change of IQGAP1 expression in ovarian CSC-LCs during their differentiation and the influence of IQGAP1 in invasion behavior of ovarian CSC-LCs in vitro. The aim of the study was to identify the role of IQGAP1 in ovarian CSC-LCs invasion capacity and possible contribution to aggressive behavior of ovarian cancer.
MATERIALS AND METHODS

Cell Line and Culture
Ovarian adenocarcinoma cell line 3AO was obtained from the Women's Hospital School of Medicine, Zhejiang University. Cells were maintained in RPMI 1640 medium (Cellgro, Virginia) supplemented with 10% fetal bovine serum (FBS, Gibco). Ovarian CSC-LCs, the tumor spheroids, were cultured at a density of 50,000 cells/mL in serum-free DMEM/ F12 medium (Cellgro, Virginia) composed of 10 ng/mL basic fibroblast growth factor and 20 ng/mL epidermal growth factor (PeproTech Inc, Rocky Hill, NJ), 1 mg/mL insulin (SigmaAldrich St Louis, MO), and 10 KL/mL B27 additive (Life Technologies, Carlsbad, CA) on ultralow attachment culture dishes (Corning, NY). All cells were maintained in a humidified atmosphere 5% CO 2 at 37-C.
Differentiation Assay of Tumor Spheres
Six days after serum-free medium (SFM) culture, cells were returned into PRIM 1640 medium with 10% FBS in individual well of a 6-well culture plate. The readhered cancer stem cells were fed with FBS-supplemented medium every 2 days, and gene or protein expression was detected after plating using real-time polymerase chain reaction (PCR) and Western blot.
Flow Cytometry
For CD24 expression quantization, 3AO cells and tumor spheroids were trypsinized to single cell and washed twice with phosphate-buffered saline (PBS). Then, 1 Â 10 6 cells were labeled with 1 unit of phycoerythrin mouse antihuman CD24 (BD Biosciences, New Jersey) and phycoerythrin Mouse IgG2a, J Isotype Control (BD Biosciences, New Jersey).
Immunofluorescence Analysis
Briefly, for immunostaining of undifferentiated tumor spheres, cells were trypsinized to single cell, then plated onto poly-L-ornithineYcoated glass cover slips in SFM for 4 hours. The 3AO cells, the adherent cells, usually grew on cover slips for 24 hours. Cells were treated with 4% paraformaldehyde, cold 0.25% Triton-X-100 (Sigma-Aldrich, St Louis, MO) following the protocol, and stained with primary antibodies against SOX2 (1:500, Santa Cruz, CA) and OCT4 (1:500, Santa Cruz, CA). Appropriate secondary antibodies (Beyotime, Jiangsu, China) were used. Cell nuclear DNA was stained with propidium iodide (Sigma-Aldrich, St Louis, MO). 
Western Blot
Cells were washed with PBS twice, dissolved, and vortexed in lysis buffer. The cell extracts were incubated on ice for 30 minutes, centrifuged at 14,000 rpm for 30 minutes, and the supernatants were collected. Protein were loaded and separated on 8% SDS-PAGE gels and transferred onto 0.45-Km transfer membranes (Corning, NY). The membranes were blocked with PBS containing 5% dried milk and 0.05% Tween 20 for 1 hour, and then probed with antibodies against GAPDH (1:2000, Santa Cruz, CA), IQGAP1 (1:5000, BD biosciences, New Jersey). Subsequently, visualization used enhanced chemiluminescence detection kit for HRP (BioInd, Israel) with the appropriate secondary antibodies (goat antimouse IgG, 1:1000; goat anti-rabbit IgG, 1:1000; Beyotime, Shanghai, China), which contained horseradish peroxidase.
RNA Extraction and Quantitative Real-Time-PCR (qRT-PCR) Assay
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) according to manufacturer's guidelines. Complementary DNA was reverse-transcribed with ReverTra Ace qPCR RT Kit (Toyobo, Japan). qRT-PCR was performed by Thunderbird Syber qPCR Mix (Toyobo, Japan) and Applied Biosystems 7900HT fast real-time PCR System FIGURE 1. IQGAP1 expression is decreased in ovarian cancer stem cells from SFM culture. A, Morphology of aggregated ovarian CSC-LCs was identified to almost 100 Km tumor spheroids (Â100). B, Flow cytometry analysis on CD24 expression in 3AO cells and ovarian CSC-LCs. C, Ovarian CSC-LCs, but not 3AO cells, retained the expression of stem cell markers OCT4 and SOX2 in nucleus (with DyLight 488, in green.). D, Stem cell markers OCT4 and SOX2 expression were compared between 3AO and CSC-LCs in mRNA level. E, The expression of IQGAP1 mRNA was compared between 3AO and CSC-LCs. F, The expression of IQGAP1 protein was compared between 3AO and CSC-LCs.
(Life Technologies, Carlsbad, CA). The relative messenger RNA (mRNA) expression levels of all genes were calculated according to the 2-$ct method. The method to present relative gene expression was the comparative CT method. For normalization, GAPDH was used as an endogenous control. Primers and sequences were shown in Table 1 .
Small Interfering RNA Transfection
Small interfering RNA (siRNA) targeting IQGAP1 and scramble siRNA-negative control were both synthesized by GenePharma (Shanghai, China). The oligonucleotide sequence was as follows: 5 ¶-GCGACAAAGUCCUGAACAUTT-3 ¶ (oligo-1), 5 ¶-AAGUUCUACGGGAAGUAAUUGTT-3 ¶ (oligo-2), and 5 ¶-UUCUCCGAACGUGUCACGUTT-3 ¶ (negative control). Before transfection, the cells were propagated to~60% confluency. Small interfering RNA and Lipofectamine RNAiMAX Transfection Reagent (Life Technologies, Carlsbad, CA) were diluted by Opti-Mem (Gibco, Life Technologies, Carlsbad, CA), respectively, according the guidelines. Cell grew for 48 to 72 hours before harvesting RNA and protein.
Transwell Invasion Assay
Cell invasion was routinely carried out in 8-Km pore polycarbonate membrane transwell chambers (Corning, NY). Inserts' membranes were coated with Matrigel (BD Biosciences) in 37-C for 30 minutes. A total of 100,000 cells were resuspended in 200 KL SFM. A 500-KL medium supplemented with 10% FBS was placed in the wells beneath the inserts to act as a chemoattractant. Cells remaining in the chamber were removed with a cotton swab, and the migrated cells situated on the lower side of membranes were fixed and stained for 20 minutes in 10% ethanol containing 0.05% crystal violet. Assays were performed in triplicate, and all photographs were taken in microscope (Â200) for graphical and statistical purposes.
Statistical Analysis
Statistical calculations were performed using SPSS 20.0. Comparisons between treatment groups were made with the 2-tailed Student t test. Results were presented as mean (SD). All P values were 2-sided, and P values less than 0.05 were considered statistically significant.
RESULTS
IQGAP1 Expression Is Decreased in Ovarian Cancer Stem Cells
To understand IQGAP1 expression in ovarian CSC-LCs cells, we initially obtained ovarian CSC-LCs through spheroid culture of 3AO cells with SFM. Over a 6-day culture period, the CSC-LCs were aggregated into almost 100-Km diameter spheroids (Fig. 1A) . We further observed that CD24 expression was significantly decreased in CSC-LCs compared with parental 3AO cells by flow cytometric quantification (positive percentage 4.50 T 1.88% vs 95.68 T 0.68%, P G 0.001) (Fig. 1B) . Compared with 3AO cells, the CSC-LCs showed remarkable immunoreactivity for stem cell markers OCT4 and SOX2 that were almost expressed in the nucleus (Fig. 1C) . Simultaneously, mRNA expressions of OCT4 and SOX2 in CSC-LCs were increased to 2.24-fold (0.54-fold) and 1.51-fold (0.46-fold), respectively (P G 0.05) (Fig. 1D ). In consistence with the expressions of CD24 and stem cell 
IQGAP1 Expression Is Increased During the Differentiation of Ovarian Cancer Stem Cells
To observe the differentiation process of ovarian CSCLCs, we choose the FBS as the inducing agent. After culture in 10% FBS medium for 4 days, the morphology of CSC-LCs changed from irregularly elongated to densely cobblestonelike shape (Fig. 2A) . Then we observed the dynamic decreasing of OCT4 and SOX2 expression from the first day to the fourth day by real-time PCR. Synchronously, the CSCLCs in undifferentiated status exhibited highest level of stem cell markers SOX2 and OCT4. As time went on, OCT4 and SOX2 expressions were rapidly declined and reduced nearly to 18.37% (12.30%) and 40.7% (14.14%) at the fourth day (P G 0.05) of differentiation culture for CSC-LCs (Fig. 2B) .
Afterwards, we observed the change of IQGAP1 expression along with the differentiation of CSC-LCs by Western blot and real-time PCR and found that IQGAP1 expression was gradually increased after cell differentiation; IQGAP1 mRNA expression achieved 2.61-fold (0.19-fold) and 3.16-fold (0.87-fold), respectively, in cells readhered for 2 days and 4 days, and IQGAP1 protein expression achieved 1.51-fold and 1.67-fold, respectively, for 2 days and 4 days, respectively (Figs. 2B, C) .
IQGAP1 Modulates Aggressive Behaviors of Ovarian Cancer Stem Cells
To understand the influence of increased IQGAP1 expression in the invasion capacity of ovarian CSC-LCs, we initially assessed the change of invasion capacity during their differentiation with transwell assays. In addition, we interestingly found enhanced invasion capability of ovarian CSC-LCs readhered for 2 days and 4 days, and the total numbers of migrated cells were 59.56 (6.28) per field in parental 3AO cells, 25.40 (4.04) in CSC-LCs readhered for 2 days, and 54.06 (3.93) for 4 days, respectively (P = 0.00071), as shown in Figure 3A . Together, our results suggest that the invasion capacity of ovarian CSC-LCs is enhanced along with increased IQGAP1 expression and cell differentiation.
We further transfected 2 IQGAP1-specific siRNAs with different sequences and negative control into parental 3AO cells. IQGAP1 expression was significantly decreased by oligo-1 and oligo-2 in mRNA level compared with negative control, but the inhibitory rate of IQGAP1 expression achieved 96.7% (3.0%) in mRNA and 70.7% in protein by oligo-1 in 3AO cells whereas only 95.1% (3.2%) in mRNA and 20.8% in protein by oligo-2. Hence, siRNA oligo-1 was preferentially chosen in the next functional experiments (Figs. 3B, C) . The siRNA oligo-1 specific to IQGAP1 and 
DISCUSSION
The concept of the cancer stem cell arises from the observation of striking similarities between the self-renewal mechanisms of stem cells and cancer cells. Because normal somatic stem cells must self-renew and maintain a relative balance between self-renewal and differentiation, cancer can be contextualized as a disease of unregulated self-renewal. 4 The consensus definition of a cancer stem cell is a cell within a tumor that possesses the capacity to self-renew and to generate the heterogeneous lineages of cancer cells that comprise the tumor, according to the American Association for Cancer Research workshop in 2006. 17 If progenitors derived from a cancer stem cell lose the capacity of self-renewal by the induction of differentiation, the cancer stem cell population would be depleted and the tumor would subsequently shrink, according to the conventional cancer stem cell model. So this new model pays equal attention to self-renewal program and asymmetric division. Differentiation is just one of the mechanisms of this process.
Previous studies have identified a new population of cancer stem cells in ovarian cancer with different phenotypes. These cancer stem cells represented a fraction of the total cells comprising the tumor, and they were identified by CD133, 18, 19 CD44, 7, 20 CD24, 21 ALDH, 20, 22 and other expressions. In our previous study, we identified that CD24(j) cells from adenocarcinoma cell line 3AO by serum-free starvation culture possessed the characteristics of CSC-LCs with higher capacity of tumorigenesis, drug resistance, selfrenewal, and differentiation abilities. Here, we purified successfully ovarian CSC-LCs by the same method applied in previous studies. 8, 9 The free-serum culture switched the percentage of the expression of CD24, a small and heavily glycosylated cell surface protein linked to the membrane. We found that stem cell markers OCT4 and SOX2 were overexpressed in ovarian CSC-LCs, then decreased strikingly when they were recultured in medium with 10% FBS. Simultaneously, the morphology of cells changed into differentiation status accompanying the loss of stem cell markers. Salvatori et al 23 reported that prostatic adenocarcinoma cancer stem cells cocultured with neuroendocrine cells in FBS medium differentiated toward a more aggressive phenotype. Just as the report of Fan et al 24 in which the migration capability was low in sphere prostate cells, but gradually increased during the sphere cells differentiation, we also found the markedly increased invasion capacity of ovarian CSC-LCs when they differentiated from tumor spheroids to the fourth day, suggesting that ovarian cancer cells obtain aggressive behavior during their differentiation from cancer stem cells, which may facilitate the cancer metastasis.
IQGAP1, located in 15q26, is a member of the IQGAP family of multidomain proteins expressed in normal tissues and cancers. As a scaffold protein, IQGAP1 contains the following binding domains: CHD, calponin-homology domain; coiled coil, predicted >-helical structure; WW, polyproline protein-protein domain; IQ, 4 IQ motifs; GRD, Ras GTPaseactivating protein-related domain; and RGCt, RasGAP Cterminus. The broad range of interacting partners places IQGAP1 as a key mediator of numerous cellular processes and signaling pathways, such as MAPK 25 and Wnt signalings. 26, 27 In human epithelial cells in culture, endogenous IQGAP1 is distributed throughout the cytoplasm and accumulates at cell-cell junctions where it colocalizes with E-cadherin. 28 Increased expression of IQGAP1 has also been observed in several human neoplasms, and IQGAP1 has been proposed to be an oncogene.
14 Here, we demonstrated that IQGAP1 expression was significantly lower in ovarian cancer stem cells than that in their parental cells and increased de novo when cells were recultured in medium culture with 10% FBS, suggesting that IQGAP1 is mainly expressed in mature cancer cells.
In consideration of IQGAP1 action in cell movement as a cytoskeleton-associated protein, we knocked down IQGAP1 expression by a specific siRNA in ovarian CSC-LCs readhered for 2 days and found that invasion capacity of cells was attenuated, suggesting that IQGAP1 is involved in enhanced aggressive behavior of ovarian CSC-LCs during differentiation. When ovarian cancer stem cells differentiate toward mature cancer cells, they up-regulate IQGAP1 expression and may contribute to the metastasis of ovarian cancer.
